pubmed-article:16484125 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0006675 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0005938 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0042866 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0043603 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
pubmed-article:16484125 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
pubmed-article:16484125 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16484125 | pubmed:dateCreated | 2006-2-17 | lld:pubmed |
pubmed-article:16484125 | pubmed:abstractText | Decreased bone mineral density (BMD) is common in inflammatory bowel disease (IBD) and an increased risk of fractures has been reported. Guidelines state bisphosphonate treatment for IBD patients with decreased BMD, but orally available bisphosphonates have been associated with gastrointestinal side effects and the absorption is poor. We investigated whether intravenous pamidronate is a safe and effective treatment. | lld:pubmed |
pubmed-article:16484125 | pubmed:language | eng | lld:pubmed |
pubmed-article:16484125 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16484125 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16484125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16484125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16484125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16484125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16484125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16484125 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16484125 | pubmed:month | Feb | lld:pubmed |
pubmed-article:16484125 | pubmed:issn | 0036-5521 | lld:pubmed |
pubmed-article:16484125 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:16484125 | pubmed:author | pubmed-author:VerberneHein... | lld:pubmed |
pubmed-article:16484125 | pubmed:author | pubmed-author:HommesDaniel... | lld:pubmed |
pubmed-article:16484125 | pubmed:author | pubmed-author:StokkersPiete... | lld:pubmed |
pubmed-article:16484125 | pubmed:author | pubmed-author:DeleyMaartjeM | lld:pubmed |
pubmed-article:16484125 | pubmed:author | pubmed-author:Van Der... | lld:pubmed |
pubmed-article:16484125 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16484125 | pubmed:volume | 41 | lld:pubmed |
pubmed-article:16484125 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16484125 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16484125 | pubmed:pagination | 200-4 | lld:pubmed |
pubmed-article:16484125 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:meshHeading | pubmed-meshheading:16484125... | lld:pubmed |
pubmed-article:16484125 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16484125 | pubmed:articleTitle | Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease. | lld:pubmed |
pubmed-article:16484125 | pubmed:affiliation | Department of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands. p.stokkers@amc.uva.nl | lld:pubmed |
pubmed-article:16484125 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16484125 | pubmed:publicationType | Comparative Study | lld:pubmed |